Mouse Consortium Completes First Phase of Mouse Genome Project | GenomeWeb

CAMBRIDGE, UK, May 8 - The public-private effort to sequence the mouse genome said Tuesday it has completed the first phase of its sequencing initiative.

The Mouse Sequencing Consortium has generated 3x coverage of the mouse genetic code, where each of the three billion DNA bases has been ‘read’ three times. Approximately 94 percent of the genome is now covered. 

The organisations that make up the $58 million consortium include the US National Institutes of Health, the Wellcome Trust, Glaxo SmithKline, the Merck Genome Research Institute and Affymetrix.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.